TWI801737B

A method for improving mild cognitive impairment of a human patient includes providing a dose of 250 mg-500 mg of a composition once or twice a day for three months or more. The human patient has mild cognitive impairment with a score of 23 points or more and less than 27 points in the Mini-Mental S...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SATO, KENICHIRO, YANAI, NOBUYA, SHIOTANI, SHIGENOBU, HISATSUNE, TATSUHIRO, MASUOKA, NOBUTAKA
Format:	Patent
Sprache:	chi
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A method for improving mild cognitive impairment of a human patient includes providing a dose of 250 mg-500 mg of a composition once or twice a day for three months or more. The human patient has mild cognitive impairment with a score of 23 points or more and less than 27 points in the Mini-Mental State Examination, a score of 0.5 in the Clinical Dementia Rating, or a score of less than 25 points in the Montreal Cognitive Assessment. The composition includes imidazole dipeptide separated and purified from chicken extract or salmon extract. The imidazole dipeptide does not contain creatinine, and 75% or more of the imidazole dipeptide in the composition is anserine.